Fully automated radiosynthesis of N1-[18F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging
Autor: | Dominique Egrise, Serge Goldman, Jean Henrottin, Alain Plenevaux, Astrid Zervosen, André Luxen, Benoît Van den Eynde, Xavier Franci, Christian Lemaire |
---|---|
Rok vydání: | 2016 |
Předmět: |
Cancer Research
Stereochemistry 030218 nuclear medicine & medical imaging Automation Mice 03 medical and health sciences 0302 clinical medicine Cell Line Tumor Animals Humans Indoleamine-Pyrrole 2 3 -Dioxygenase Radiology Nuclear Medicine and imaging Indoleamine 2 3-dioxygenase Fluoroethyl Radiochemistry Chemistry Radiosynthesis Tryptophan Substrate (chemistry) Biological Transport Stereoisomerism Biological activity In vitro Chiral column chromatography Positron-Emission Tomography 030220 oncology & carcinogenesis Molecular Medicine Specific activity Hydrophobic and Hydrophilic Interactions |
Zdroj: | Nuclear Medicine and Biology. 43:379-389 |
ISSN: | 0969-8051 |
DOI: | 10.1016/j.nucmedbio.2016.03.001 |
Popis: | Introduction Indoleamine 2,3-dioxygenase (IDO) catalyzes the initial step in the catabolism of l-tryptophan along the kynurenine pathway and exerts immunosuppressive properties in inflammatory and tumor tissues by blocking locally T-lymphocyte proliferation. Recently, 1-(2-[ 19 F]fluoroethyl)-dl-tryptophan (1-[ 19 F]FE-dl-Trp) was reported as a good and specific substrate of this enzyme. Herein, the radiosynthesis of its radioactive isotopomer (1-[ 18 F]FE-dl-Trp, dl-[ 18 F] 5 ) is presented along with in vitro enzymatic and cellular uptake studies. Methods The one-pot n.c.a. radiosynthesis of this novel potential PET imaging tracer, including HPLC purification and formulation, has been fully automated on a FASTlab™ synthesizer. Chiral separation of both isomers and their formulation were implemented on a second cassette. In vitro enzymatic and cellular uptake studies were then conducted with the d-, l- and dl-radiotracers. Results The radiolabeling of the tosylate precursor was performed in DMF (in 5min; RCY: 57% (d.c.), n=3). After hydrolysis, HPLC purification and formulation, dl-[ 18 F] 5 was obtained with a global radiochemical yield of 18±3% (not decay corrected, n=7, in 80min) and a specific activity of 600±180GBq/μmol (n=5). The subsequent separation of l- and d-enantiomers was performed by chiral HPLC and both were obtained after formulation with an RCY (d.c.) of 6.1% and 5.8%, respectively. In vitro enzymatic assays reveal that l-[ 18 F] 5 is a better substrate than d-[ 18 F] 5 for human IDO. In vitro cellular assays show an IDO-specific uptake of the racemate varying from 30% to 50% of that of l-[ 18 F] 5 , and a negligible uptake of d-[ 18 F] 5 . Conclusion In vitro studies show that l-[ 18 F] 5 is a good and specific substrate of hIDO, while presenting a very low efflux. These results confirm that l-[ 18 F] 5 could be a very useful PET radiotracer for IDO expressing cells in cancer imaging. |
Databáze: | OpenAIRE |
Externí odkaz: |